Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study

Almeida, AM, Prebet, T, Itzykson, R, Ramos, F, Al-Ali, H, Shammo, J, Pinto, R, Maurillo, L, Wetzel, J, Musto, P, Van De Loosdrecht, AA, Costa, MJ, Esteves, S, Burgstaller, S, Stauder, R, Autzinger, EM, Lang, A, Krippl, P, Geissler, D, Falantes, JF, Pedro, C, Bargay, J, Deben, G, Garrido, A, Bonanad, S, Diez-Campelo, M, Thepot, S, Ades, L, Sperr, WR, Valent, P, Fenaux, P, Sekeres, MA, Greil, R, Pleyer, L. INT J MOL SCI. 2017, 18(4): 837.

Differences in stem cell processing lead to distinct secretomes secretion – implications for differential results of previous clinical trials of stem cell therapy for myocardial infarction.

Wernly, B, Gonçalves, I, Kiss, A, Paar, V, Mösenlechner, T, Leisch, M, Santer, D, Motloch, L, Klein, KU, Tretter, EV, Kretzschmar, D, Podesser, B, Jung, C, Hoppe, UC, Lichtenauer, M. Biotechnol J. 2017.

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.

Magnes, T, Melchardt, T, Hufnagl, C, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Rinnerthaler, G, Roesch, S, Gaggl, A, Greil, R, Egle, A. Pharmacogenomics J. 2017.

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

Magnes, T, Melchardt, T, Weiss, L, Mittermair, C, Neureiter, D, Klieser, E, Gampenrieder, S, Moser, G, Gaggl, A, Greil, R, Egle, A. PLoS One. 2017, 12(7):e0180995.

SABCS 2016: systemic therapy for metastatic breast cancer.

Gampenrieder, SP, Rinnerthaler, G, Greil, R. MEMO-MAG EUR MED ONC. 2017, 10(2): 86-89.

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

nnerthaler, G, Romeder, F, M. J Clin Oncol. 2017, 35(22):2473-2481.

Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine – A retrospective single center experience.

Leisch, M, Weiss, L, Lindlbauer, N, Jungbauer, C, Egle, A, Rohde, E, Greil, R, Grabmer, C, Pleyer, L. Leuk Res. 2017, 59:12-19.

COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.

Hainzl, S, Peking, P, Kocher, T, Murauer, EM, Larcher, F, Del Rio, M, Duarte, B, Steiner, M, Klausegger, A, Bauer, JW, Reichelt, J, Koller, U. Mol Ther. 2017.

Azacitidine in adult patients with acute myeloid leukemia.

Schuh, AC, Dohner, H, Pleyer, L, Seymour, JF, Fenaux, P, Dombreth, H. Crit Rev Oncol Hematol. 2017, 116:159-177.

Improvement of quality of life and psychological distress after inpatient cancer rehabilitation.

Riedl, D, Giesinger, JM, Wintner, LM, Loth, FL, Rumpold, G, Greil, R, Nickels, A, Licht, T, Holzner, B. WIEN KLIN WOCHENSCHR. 2017, 129(19-20): 692-701.